Bristol Myers Squibb (BMY)

R&D to Revenue

20.65%

Fiscal year · Period ending:

BMY logo

BMY R&D to Revenue

Latest reported20.65%
BMY FY R&D/Revenue (0.00% → 20.65%)
High-resolution chart · PNG

BMY r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
20.6474%
23.1035%
20.6617%
20.6005%
21.9791%
26.2077%
23.515%
28.0661%
31.1321%
25.7991%
35.7488%
28.5534%
22.7708%
22.1554%
18.071%
18.3022%
19.3907%
17.051%
16.963%
16.6964%
13.9428%
12.8999%
10.9074%
12.1751%
11.2393%
10.6445%
8.6984%
8.2367%
8.2929%
8.47%
8.7092%
9.2457%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.